Tenax Therapeutics, Inc. (TENX)
11.87
+0.18
(+1.54%)
USD |
NASDAQ |
May 29, 16:00
11.88
+0.01
(+0.08%)
Pre-Market: 20:00
Tenax Therapeutics EPS Diluted (Quarterly) : -0.3475 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Exicure, Inc. | -0.4547 |
| Century Therapeutics, Inc. | -0.1119 |
| Absci Corp. | -0.1935 |
| Celularity, Inc. | -0.8477 |
| Cardio Diagnostics Holdings, Inc. | -0.6295 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.72M |
| Total Expenses (Quarterly) | 15.72M |
| Enterprise Value | 196.10M |
| Earnings Yield | -11.79% |
| Normalized Earnings Yield | -11.79 |